Literature DB >> 19529899

Inflammatory bowel disease and coronary artery disease.

Raja Shekhar R Sappati Biyyani1, Nabil M Fahmy, Elizabeth Baum, Karl M Nelson, James F King.   

Abstract

Chronic inflammation with the presence of excess serum acute-phase proteins, cytokines and cell adhesion molecules is increasingly being implicated in atherosclerosis. The association between inflammatory bowel disease (IBD) and coronary artery disease (CAD) is unstudied. This is a preliminary, thesis-generating cross-sectional study aimed at evaluating the presence of traditional atherosclerotic risk factors in patients with IBD and CAD compared with the control population. The medical records of 42 consecutive IBD patients with CAD from 1999 to 2005 (27 men) were reviewed for the Framingham risk factors. The Framingham risk score (FRS) is calculated based on age, sex, hypertension, diabetes and hyperlipidemia. FRS of patients with IBD and CAD was compared with the FRS of 137 age- and sex-matched (102 men) consecutive patients with CAD (controls). When the Framingham risk score adjusted for group and gender with age as a covariate, the adjusted total FRS score was higher in patients with CAD alone (10.0 [3.75]) as compared to those with; IBD and CAD: (8.1 [3.47]; p = 0.001). FRS is lower in cases (patients with IBD and CAD) when compared with the controls (CAD alone).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19529899     DOI: 10.1007/s12664-009-0006-3

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  10 in total

1.  Cause of death in patients with inflammatory bowel disease.

Authors:  C Cucino; A Sonnenberg
Journal:  Inflamm Bowel Dis       Date:  2001-08       Impact factor: 5.325

2.  The role of inflammatory cytokines in the pathogenesis of systemic lupus erythematosus-related atherosclerosis: a novel target for treatment?

Authors:  Ora Shovman; Boris Gilburd; Yehuda Shoenfeld
Journal:  J Rheumatol       Date:  2006-03       Impact factor: 4.666

3.  Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease.

Authors:  V Kupcová; L Turecký; Z Detková; M Príkazská; A Keleová
Journal:  Physiol Res       Date:  2003       Impact factor: 1.881

4.  Treatment of Crohn's disease with anti-IL-6 receptor antibody.

Authors:  Hiroaki Ito
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

5.  Soluble adhesion molecules in inflammatory bowel disease.

Authors:  M G Goggins; J Goh; M A O'Connell; D G Weir; D Kelleher; N Mahmud
Journal:  Ir J Med Sci       Date:  2001 Apr-Jun       Impact factor: 1.568

Review 6.  Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

Authors:  Hilal Maradit-Kremers; Cynthia S Crowson; Paulo J Nicola; Karla V Ballman; Véronique L Roger; Steve J Jacobsen; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-02

Review 7.  Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

Authors:  Paul M Ridker; Peter W F Wilson; Scott M Grundy
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

8.  Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated C-reactive protein levels.

Authors:  Efthymios N Deliargyris; Phoebus N Madianos; Waka Kadoma; Irene Marron; Sidney C Smith; James D Beck; Steven Offenbacher
Journal:  Am Heart J       Date:  2004-06       Impact factor: 4.749

Review 9.  Assessing coronary heart disease risk with traditional and novel risk factors.

Authors:  Peter W F Wilson
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

Review 10.  Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi
Journal:  Nephrol Dial Transplant       Date:  2004-08       Impact factor: 5.992

  10 in total
  5 in total

Review 1.  Risk of cardiovascular disease in inflammatory bowel disease.

Authors:  Nynne Nyboe Andersen; Tine Jess
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 2.  Epidemiology, risk factors and management of cardiovascular diseases in IBD.

Authors:  Siddharth Singh; Iftikhar J Kullo; Darrell S Pardi; Edward V Loftus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

3.  Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease.

Authors:  Fenling Fan; Abby Galvin; Lu Fang; David Andrew White; Xiao-Lei Moore; Miles Sparrow; Flavia Cicuttini; Anthony Michael Dart
Journal:  J Inflamm (Lond)       Date:  2014-10-11       Impact factor: 4.981

4.  The role of adhesion molecules in inflammatory bowel disease in children. Assessment of the possible risk of cardiovascular complications.

Authors:  Aneta Trzeciak-Jędrzejczyk; Ryszard Makosiej; Michał Kolejwa; Ewa Głowacka; Elżbieta Czkwianianc
Journal:  Prz Gastroenterol       Date:  2017-09-30

5.  Association of bowel and tear suppression with coronary artery disease: A case control study.

Authors:  N Nifina; Anupama Krishnan
Journal:  J Ayurveda Integr Med       Date:  2021-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.